Just as a map shows you how to reach a destination in the real world, Ampersand Biomedicines’ map of tissues of the human body shows where a drug should go in the biological one. Now the startup has ...
In TV Ad Land, the road to streaming media convergence still stretches far into the distance. TV content may be bundled into streaming services, but from the advertiser standpoint, the data is still ...
Ampersand's AND™ Platform will be used to identify programmed biologics for the treatment of obesity-related targets Montai's CONECTA™ AI platform will be used to identify small molecules directed to ...
GHO Capital Partners and Ampersand Capital Partners have successfully completed the acquisition of Avid Bioservices, a biologics contract development and manufacturing organization, in an all-cash ...
Just days after laying out $90 million to acquire Nektar Therapeutics’ Alabama manufacturing plant, Ampersand Capital Partners is pulling out its life sciences checkbook once again. This week, ...
“On TV & Video” is a column exploring opportunities and challenges in advanced TV and video. Convergent TV isn’t just about marrying linear and streaming TV. Linear has its own fragmentation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results